메뉴 건너뛰기




Volumn 19, Issue 5, 2012, Pages 523-527

Therapeutic strategies for hepatic metastasis of colorectal cancer: Overview

Author keywords

Cascade theory; Hepatectomy; Preoperative chemotherapy

Indexed keywords

FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

EID: 84867328215     PISSN: 18686974     EISSN: 18686982     Source Type: Journal    
DOI: 10.1007/s00534-012-0524-8     Document Type: Article
Times cited : (27)

References (29)
  • 1
    • 0022969737 scopus 로고
    • Haematogenous metastatic patterns in colonic carcinoma: An analysis of 1541 necropsies
    • Weiss L, Grundmann E, Torhorst J, Hartveit F, Moberg I, Eder M, et al. Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies. J Pathol. 1986;150:195-203.
    • (1986) J Pathol , vol.150 , pp. 195-203
    • Weiss, L.1    Grundmann, E.2    Torhorst, J.3    Hartveit, F.4    Moberg, I.5    Eder, M.6
  • 3
    • 0034126372 scopus 로고    scopus 로고
    • Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization
    • Azoulay D, Castaing D, Smail A, Adam R, Cailliez V, Laurent A, et al. Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg. 2000;231:480-6.
    • (2000) Ann Surg , vol.231 , pp. 480-486
    • Azoulay, D.1    Castaing, D.2    Smail, A.3    Adam, R.4    Cailliez, V.5    Laurent, A.6
  • 4
    • 0033658667 scopus 로고    scopus 로고
    • Twostage hepatectomy: A planned strategy to treat irresectable liver tumors
    • Adam R, Laurent A, Azoulay D, Castaing D, Bismuth H. Twostage hepatectomy: a planned strategy to treat irresectable liver tumors. Ann Surg. 2000;232:777-85.
    • (2000) Ann Surg , vol.232 , pp. 777-785
    • Adam, R.1    Laurent, A.2    Azoulay, D.3    Castaing, D.4    Bismuth, H.5
  • 5
    • 2442704240 scopus 로고    scopus 로고
    • Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases
    • Abdalla EK, Vauthey JN, Ellis LM, Ellis V, Pollock R, Broglio KR, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg. 2004;239:818-25.
    • (2004) Ann Surg , vol.239 , pp. 818-825
    • Abdalla, E.K.1    Vauthey, J.N.2    Ellis, L.M.3    Ellis, V.4    Pollock, R.5    Broglio, K.R.6
  • 6
    • 4644320061 scopus 로고    scopus 로고
    • Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: A model to predict long-term survival
    • Adam R, Delvart V, Pascal G, Valeanu A, Castaing D, Azoulay D, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg. 2004;240:644-57.
    • (2004) Ann Surg , vol.240 , pp. 644-657
    • Adam, R.1    Delvart, V.2    Pascal, G.3    Valeanu, A.4    Castaing, D.5    Azoulay, D.6
  • 7
    • 0034036478 scopus 로고    scopus 로고
    • Interval hepatic resection of colorectal metastases improves patient selection
    • Lambert LA, Colacchio TA, Barth RJ. Interval hepatic resection of colorectal metastases improves patient selection. Arch Surg. 2000;135:473-9.
    • (2000) Arch Surg , vol.135 , pp. 473-479
    • Lambert, L.A.1    Colacchio, T.A.2    Barth, R.J.3
  • 8
    • 0142122503 scopus 로고    scopus 로고
    • Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy: Analysis of prognostic factors for 763 cases recorded at 18 institutions
    • Kato T, Yasui K, Hirai T, Kanemitsu Y, Mori T, Sugihara K, et al. Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy: analysis of prognostic factors for 763 cases recorded at 18 institutions. Dis Colon Rectum. 2003;46:S22-31.
    • (2003) Dis Colon Rectum , vol.46
    • Kato, T.1    Yasui, K.2    Hirai, T.3    Kanemitsu, Y.4    Mori, T.5    Sugihara, K.6
  • 9
    • 79959740774 scopus 로고    scopus 로고
    • XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results
    • Cassidy J, Clarke S, Di'az-Rubio E, Scheithauer W, Figer A, Wong R, et al. XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results. Br J Cancer. 2011;105:58-64.
    • (2011) Br J Cancer , vol.105 , pp. 58-64
    • Cassidy, J.1    Clarke, S.2    Di'Az-Rubio, E.3    Scheithauer, W.4    Figer, A.5    Wong, R.6
  • 10
    • 66149120036 scopus 로고    scopus 로고
    • Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: The BEAT study
    • Van Cutsem E, Rivera F, Berry S, Kretzschmar A, Michael M, DiBartolomeo M, et al. Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study. Ann Oncol. 2009;20:1842-7.
    • (2009) Ann Oncol , vol.20 , pp. 1842-1847
    • Van Cutsem, E.1    Rivera, F.2    Berry, S.3    Kretzschmar, A.4    Michael, M.5    Dibartolomeo, M.6
  • 11
    • 33644697486 scopus 로고    scopus 로고
    • Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinoma
    • Folprecht G, Lutz MP, Schöffski P, Seufferlein T, Nolting A, Pollert P, et al. Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinoma. Ann Oncol. 2006;17:450-6.
    • (2006) Ann Oncol , vol.17 , pp. 450-456
    • Folprecht, G.1    Lutz, M.P.2    Schöffski, P.3    Seufferlein, T.4    Nolting, A.5    Pollert, P.6
  • 12
    • 78149250536 scopus 로고    scopus 로고
    • Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: The PRIME study
    • Douillard JY, Siena S, Cassidy J, Tabernero J, Burkes R, Barugel M, et al. Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study. J Clin Oncol. 2010;28:4697-705.
    • (2010) J Clin Oncol , vol.28 , pp. 4697-4705
    • Douillard, J.Y.1    Siena, S.2    Cassidy, J.3    Tabernero, J.4    Burkes, R.5    Barugel, M.6
  • 13
    • 0023552654 scopus 로고
    • A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases
    • Chang AE, Schneider PD, Sugarbaker PH, Simpson C, Culnane M, Steinberg SM. A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg. 1987;206:685-93.
    • (1987) Ann Surg , vol.206 , pp. 685-693
    • Chang, A.E.1    Schneider, P.D.2    Sugarbaker, P.H.3    Simpson, C.4    Culnane, M.5    Steinberg, S.M.6
  • 14
    • 0024425297 scopus 로고
    • A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: The Northern California Oncology Group Trial
    • Hohn DC, Stagg RJ, Friedman MA, Hannigan JF Jr, Rayner A, Ignoffo RJ, et al. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: The Northern California Oncology Group Trial. J Clin Oncol. 1989;7:1646-54.
    • (1989) J Clin Oncol , vol.7 , pp. 1646-1654
    • Hohn, D.C.1    Stagg, R.J.2    Friedman, M.A.3    Hannigan Jr., J.F.4    Rayner, A.5    Ignoffo, R.J.6
  • 15
    • 37649015497 scopus 로고    scopus 로고
    • Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer
    • Mocellin S, Pilati P, Lise M, Nitti D. Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer. J Clin Oncol. 2007;25:5649-54.
    • (2007) J Clin Oncol , vol.25 , pp. 5649-5654
    • Mocellin, S.1    Pilati, P.2    Lise, M.3    Nitti, D.4
  • 16
    • 23844448040 scopus 로고    scopus 로고
    • Neoadjuvant treatment of unresectable colorectal liver metastases: Correlation between tumour response and resection rates
    • Folprecht G, Grothey A, Alberts S, Raab HR, Köhne CH. Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates. Ann Oncol. 2005;16:1311-9.
    • (2005) Ann Oncol , vol.16 , pp. 1311-1319
    • Folprecht, G.1    Grothey, A.2    Alberts, S.3    Raab, H.R.4    Köhne, C.H.5
  • 17
    • 2642541197 scopus 로고    scopus 로고
    • Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients
    • Pozzo C, Basso M, Cassano A, Quirino M, Schinzari G, Trigila N, et al. Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients. Ann Oncol. 2004;15:933-9.
    • (2004) Ann Oncol , vol.15 , pp. 933-939
    • Pozzo, C.1    Basso, M.2    Cassano, A.3    Quirino, M.4    Schinzari, G.5    Trigila, N.6
  • 18
    • 1342290189 scopus 로고    scopus 로고
    • FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: A randomized GERCOR study
    • Tournigand C, André T, Achille E, Lledo G, Flesh M, Mery-Mignard D, et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol. 2004;22:229-37.
    • (2004) J Clin Oncol , vol.22 , pp. 229-237
    • Tournigand, C.1    André, T.2    Achille, E.3    Lledo, G.4    Flesh, M.5    Mery-Mignard, D.6
  • 19
    • 40749149728 scopus 로고    scopus 로고
    • Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): A randomised controlled trial
    • Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet. 2008;371:1007-16.
    • (2008) Lancet , vol.371 , pp. 1007-1016
    • Nordlinger, B.1    Sorbye, H.2    Glimelius, B.3    Poston, G.J.4    Schlag, P.M.5    Rougier, P.6
  • 20
    • 0029794696 scopus 로고    scopus 로고
    • Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy
    • Bismuth H, Adam R, Lévi F, Farabos C, Waechter F, Castaing D, et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg. 1996;224: 509-22.
    • (1996) Ann Surg , vol.224 , pp. 509-522
    • Bismuth, H.1    Adam, R.2    Lévi, F.3    Farabos, C.4    Waechter, F.5    Castaing, D.6
  • 21
    • 30944445619 scopus 로고    scopus 로고
    • Treatment with 5-fluorouracil/folinic acid, oxaliplatin, and irinotecan enables surgical resection of metastases in patients with initially unresectable metastatic colorectal cancer
    • Masi G, Cupini S, Marcucci L, Cerri E, Loupakis F, Allegrini G, et al. Treatment with 5-fluorouracil/folinic acid, oxaliplatin, and irinotecan enables surgical resection of metastases in patients with initially unresectable metastatic colorectal cancer. Ann Surg Oncol. 2006;13:58-65.
    • (2006) Ann Surg Oncol , vol.13 , pp. 58-65
    • Masi, G.1    Cupini, S.2    Marcucci, L.3    Cerri, E.4    Loupakis, F.5    Allegrini, G.6
  • 22
    • 34249000361 scopus 로고    scopus 로고
    • Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: The Gruppo Oncologico Nord Ovest
    • Falcone A, Ricci S, Brunetti I, Pfanner E, Allegrini G, Barbara C, et al. Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest. J Clin Oncol. 2007;25:1670-6.
    • (2007) J Clin Oncol , vol.25 , pp. 1670-1676
    • Falcone, A.1    Ricci, S.2    Brunetti, I.3    Pfanner, E.4    Allegrini, G.5    Barbara, C.6
  • 23
    • 0032791959 scopus 로고    scopus 로고
    • Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery
    • Giacchetti S, Itzhaki M, Gruia G, Adam R, Zidani R, Kunstlinger F, et al. Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol. 1999;10:663-39.
    • (1999) Ann Oncol , vol.10 , pp. 663-649
    • Giacchetti, S.1    Itzhaki, M.2    Gruia, G.3    Adam, R.4    Zidani, R.5    Kunstlinger, F.6
  • 24
    • 33644819672 scopus 로고    scopus 로고
    • Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: A North Central Cancer Treatment Group phase II study
    • Alberts SR, Horvath WL, Sternfeld WC, Goldberg RM, Mahoney MR, Dakhil SR, et al. Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study. J Clin Oncol. 2005;23:9243-9.
    • (2005) J Clin Oncol , vol.23 , pp. 9243-9249
    • Alberts, S.R.1    Horvath, W.L.2    Sternfeld, W.C.3    Goldberg, R.M.4    Mahoney, M.R.5    Dakhil, S.R.6
  • 25
    • 33646457231 scopus 로고    scopus 로고
    • Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases
    • Vauthey JN, Pawlik TM, Ribero D, Wu TT, Zorzi D, Hoff PM, et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol. 2006;24:2065-72.
    • (2006) J Clin Oncol , vol.24 , pp. 2065-2072
    • Vauthey, J.N.1    Pawlik, T.M.2    Ribero, D.3    Wu, T.T.4    Zorzi, D.5    Hoff, P.M.6
  • 26
    • 33750962938 scopus 로고    scopus 로고
    • Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial
    • Portier G, Elias D, Bouche O, Rougier P, Bosset JF, Saric J, et al. Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial. J Clin Oncol. 2006;24:4976-82.
    • (2006) J Clin Oncol , vol.24 , pp. 4976-4982
    • Portier, G.1    Elias, D.2    Bouche, O.3    Rougier, P.4    Bosset, J.F.5    Saric, J.6
  • 27
    • 73249130298 scopus 로고    scopus 로고
    • Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: The CELIM randomised phase 2 trial
    • Folprecht G, Gruenberger T, Bechstein WO, Raab HR, Lordick F, Hartmann JT, et al. Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial. Lancet Oncol. 2010;11:38-47.
    • (2010) Lancet Oncol , vol.11 , pp. 38-47
    • Folprecht, G.1    Gruenberger, T.2    Bechstein, W.O.3    Raab, H.R.4    Lordick, F.5    Hartmann, J.T.6
  • 28
    • 75449110555 scopus 로고    scopus 로고
    • Perioperative chemotherapy with bevacizumab and liver resection for colorectal cancer liver metastasis
    • Chaudhury P, Hassanain M, Bouganim N, Salman A, Kavan P, Metrakos P. Perioperative chemotherapy with bevacizumab and liver resection for colorectal cancer liver metastasis. HPB (Oxford). 2010;12:37-42.
    • (2010) HPB (Oxford) , vol.12 , pp. 37-42
    • Chaudhury, P.1    Hassanain, M.2    Bouganim, N.3    Salman, A.4    Kavan, P.5    Metrakos, P.6
  • 29
    • 33748460684 scopus 로고    scopus 로고
    • Complete response of colorectal liver metastases after chemotherapy: Does it mean cure?
    • Benoist S, Brouquet A, Penna C, Julié C, El Hajjam M, Chagnon S, et al. Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J Clin Oncol. 2006;24: 3939-45.
    • (2006) J Clin Oncol , vol.24 , pp. 3939-3945
    • Benoist, S.1    Brouquet, A.2    Penna, C.3    Julié, C.4    El Hajjam, M.5    Chagnon, S.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.